GlassScriptPhysician profile
Arshia Roohian
NPI 1073507968
$1,859.85
in general payments reported to CMS, 2019-2025
17 companies · $118 in 2025
The $118 reported for 2025 was less than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $71.79 · 2020: $107 · 2021: $24.71 · 2022: $32.23 · 2023: $1,162 · 2024: $343 · 2025: $118.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $1,096 · Food and Beverage: $528.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $1,096.00 |
| Food and Beverage | $527.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Djo, LLC | $1,096.00 | 2023 | Dr Comfort |
| Amgen INC. | $266.64 | 2024 | Krystexxa |
| Smith+Nephew, INC. | $109.46 | 2020-2024 | Renasys Touch, Renasys Go V2 Home, Pico |
| Biotissue Holdings INC. | $102.63 | 2021-2025 | |
| Insulet Corporation | $45.86 | 2023 | Omnipod |
| Resmed Corp | $32.23 | 2022 | |
| Zimmer Biomet Holdings, INC. | $28.12 | 2019-2020 | |
| Kyowa Kirin, INC. | $27.97 | 2025 | |
| Averitas Pharma INC. | $21.32 | 2024 | Qutenza |
| Bioventus LLC | $21.32 | 2019 | |
| Misonix INC | $20.40 | 2019 | |
| Paratek Pharmaceuticals, INC. | $17.24 | 2025 | Nuzyra |
| Mannkind Corporation | $16.49 | 2024 | |
| Stryker Corporation | $14.67 | 2020 | |
| Forte Bio-Pharma LLC | $14.47 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tactile Systems Technology INC | $13.61 | 2020 | |
| Nevro Corp. | $11.42 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arshia Roohian listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.